|
Re: My hope for tomorrow...
|
5
|
Resverlogix Corp.
|
Jun 09, 2020 11:29PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
5
|
Resverlogix Corp.
|
Jan 08, 2019 12:32PM
|
|
Re: Comments on the AGM
|
5
|
Resverlogix Corp.
|
Nov 11, 2019 02:05AM
|
|
Re: And there's the news, 3 month loan extension....
|
5
|
Resverlogix Corp.
|
May 02, 2019 11:37PM
|
|
Re: Zenith MD&A posted to SEDAR 8/23/18
|
5
|
Zenith Epigenetics
|
Sep 01, 2018 01:35PM
|
|
Re: A Special Meeting of Shareholders?
|
5
|
Resverlogix Corp.
|
Jun 06, 2024 05:27PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
5
|
Resverlogix Corp.
|
Mar 25, 2022 06:45PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
5
|
Zenith Epigenetics
|
Jul 22, 2019 09:19AM
|
|
Re: Here's what I'd like to see - a 1:5 Reverse coupled with a listing on the Naz
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 10:45AM
|
|
Re: Please hurry RVX
|
5
|
Resverlogix Corp.
|
Apr 16, 2021 12:19PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Sep 19, 2017 01:04PM
|
|
Re: Are BP doing their DD already on Apabetalone,..
|
5
|
Resverlogix Corp.
|
Feb 14, 2019 11:09AM
|
|
Re: FDA greenlights Eli Lilly COVID-19 combo therapy
|
5
|
Resverlogix Corp.
|
Mar 10, 2021 04:42PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
5
|
Resverlogix Corp.
|
Sep 06, 2017 09:12PM
|
|
Re: Narrowing wedge...
|
5
|
Resverlogix Corp.
|
Feb 10, 2020 01:37PM
|
|
Re: Canadian Securities Administrators
|
5
|
Resverlogix Corp.
|
May 16, 2024 02:14AM
|
|
Re: Updated List of BET inhibitors
|
5
|
Zenith Epigenetics
|
Apr 10, 2019 03:27PM
|
|
Re: SELECTIVE bet inhibitors - The Next Major Scientific Breakthrough in Health Sciences
|
5
|
Resverlogix Corp.
|
Nov 22, 2017 12:27PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
5
|
Resverlogix Corp.
|
Dec 01, 2018 02:59PM
|
|
Re: More news on the way? They say things happen in 3s.....
|
5
|
Resverlogix Corp.
|
May 30, 2017 02:46AM
|
